Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part II: In vitro and in vivo Kinetics Study

References

• Dasgupta A, Biancacci I, Kiessling F, Lammers T. Imaging-assisted anticancer nanotherapy. Theranostics. 2020;10(3):956–967. doi:10.7150/thno.3828831938045
   PubMed Web of Science ®Google Scholar
• Golombek SK, May J-N, Theek B, et al. Tumor targeting via EPR: strategies to enhance patient responses. Adv Drug Deliv Rev. 2018;130:17–38. doi:10.1016/j.addr.2018.07.00730009886
   PubMed Web of Science ®Google Scholar
• Danhier F, Breton AL, Préat V. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm. 2012;9(11):2961–2973. doi:10.1021/mp300273322967287
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14(1):1–16. doi:10.1146/annurev-bioeng-071811-15012422524388
   PubMedGoogle Scholar
• Mundra V, Li W, Mahato RI. Nanoparticle-mediated drug delivery for treating melanoma. Nanomedicine (Lond). 2015;10(16):2613–2633. doi:10.2217/nnm.15.11126244818
   PubMed Web of Science ®Google Scholar
• Kwon IK, Lee SC, Han B, Park K. Analysis on the current status of targeted drug delivery to tumors. J Control Release. 2012;164(2):108–114. doi:10.1016/j.jconrel.2012.07.01022800574
   PubMed Web of Science ®Google Scholar
• Manzano M, Vallet-Regí M. Mesoporous silica nanoparticles for drug delivery. Adv Funct Mater. 2020;30(2):3–5. doi:10.1002/adfm.201902634
   Web of Science ®Google Scholar
• Prabha S, Arya G, Chandra R, Ahmed B, Nimesh S. Effect of size on biological properties of nanoparticles employed in gene delivery. Artif Cells Nanomed Biotechnol. 2016;44(1):83–91. doi:10.3109/21691401.2014.91305424866724
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu AT, Cornejo YR, Van Haute D, Berlin JM, Tortiglione C. A systematic comparison of in vitro cell uptake and in vivo biodistribution for three classes of gold nanoparticles with saturated PEG coatings. PLoS One. 2020;15(7):e0234916. doi:10.1371/journal.pone.023491632614882
   PubMed Web of Science ®Google Scholar
• Liu H, Wang J, Li W, Hu J, Wang M, Kang Y. Cellular uptake behaviors of rigidity-tunable dendrimers. Pharmaceutics. 2018;10(3):99. doi:10.3390/pharmaceutics10030099
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang L, Wang J, et al. Tunable rigidity of (Polymeric Core)-(Lipid Shell) nanoparticles for regulated cellular uptake. Adv Mater. 2015;27(8):1402–1407. doi:10.1002/adma.20140478825529120
   PubMed Web of Science ®Google Scholar
• Yameen B, Choi WI, Vilos C, Swami A, Shi J, Farokhzad OC. Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release. 2014;190:485–499. doi:10.1016/j.jconrel.2014.06.03824984011
   PubMed Web of Science ®Google Scholar
• Xu J, Gattacceca F, Amiji M. Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice. Mol Pharm. 2013;10(5):2031–2044. doi:10.1021/mp400054e23544877
   PubMedGoogle Scholar
• Voigt J, Christensen J, Shastri VP. Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc Natl Acad Sci. 2014;111(8):2942–2947. doi:10.1073/pnas.132235611124516167
   PubMed Web of Science ®Google Scholar
• Milane L, Duan Z, Amiji M. Biodistribution and pharmacokinetic analysis of combination lonidamine and paclitaxel delivery in an orthotopic animal model of multi-drug resistant breast cancer using EGFR- targeted polymeric nanoparticles. Nanomedicine. 2011;7(4):435–444. doi:10.1016/j.nano.2010.12.00921220050
   PubMedGoogle Scholar
• Chen WC, Zhang AX, Li S-D. Limitations and niches of the active targeting approach for nanoparticle drug delivery. Eur J Nanomed. 2012;4(2–4):89–93. doi:10.1515/ejnm-2012-0010
   Google Scholar
• Francia V, Yang K, Deville S, Reker-Smit C, Nelissen I, Salvati A. Corona composition can affect the mechanisms cells use to internalize nanoparticles. ACS Nano. 2019;13(10):11107–11121. doi:10.1021/acsnano.9b0382431525954
   PubMed Web of Science ®Google Scholar
• Gossmann R, Fahrländer E, Hummel M, Mulac D, Brockmeyer J, Langer K. Comparative examination of adsorption of serum proteins on HSA- and PLGA-based nanoparticles using SDS–PAGE and LC–MS. Eur J Pharm Biopharm. 2015;93:80–87. doi:10.1016/J.EJPB.2015.03.02125813886
   PubMed Web of Science ®Google Scholar
• Weber C, Simon J, Mailänder V, Morsbach S, Landfester K. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins. Acta Biomater. 2018;76:217–224. doi:10.1016/j.actbio.2018.05.05729885856
   PubMed Web of Science ®Google Scholar
• Liu N, Tang M, Ding J. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells. Chemosphere. 2020. doi:10.1016/j.chemosphere.2019.125624
   Web of Science ®Google Scholar
• Hu Z, Zhang H, Zhang Y, Wu R, Zou H. Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles. Colloids Surf B Biointerfaces. 2014;121:354–361. doi:10.1016/j.colsurfb.2014.06.01624974013
   PubMed Web of Science ®Google Scholar
• Simon J, Müller LK, Kokkinopoulou M, et al. Exploiting the biomolecular corona: pre-coating of nanoparticles enables controlled cellular interactions. Nanoscale. 2018;10(22):10731–10739. doi:10.1039/C8NR03331E29845991
   PubMed Web of Science ®Google Scholar
• Lesniak A, Fenaroli F, Monopoli MP, Åberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano. 2012;6(7):5845–5857. doi:10.1021/nn300223w22721453
   PubMed Web of Science ®Google Scholar
• Cagliani R, Gatto F, Bardi G. Protein adsorption: a feasible method for nanoparticle functionalization? Materials. 2019;12(12):1991. doi:10.3390/ma12121991
   PubMed Web of Science ®Google Scholar
• Chen D, Ganesh S, Wang W, Amiji M. The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles. Nanoscale. 2019;11(18):8760–8775. doi:10.1039/c8nr09855g30793730
   PubMed Web of Science ®Google Scholar
• Tonigold M, Simon J, Estupiñán D, et al. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona. Nat Nanotechnol. 2018;13(9):862–869. doi:10.1038/s41565-018-0171-629915272
   PubMed Web of Science ®Google Scholar
• Sebak A, Gomaa I, ElMeshad A, et al. Distinct proteins in protein corona of nanoparticles represent a promising venue for endogenous targeting part I: in vitro release and uptake perspective. Int J Nanomed. 2020;15:8845–8862. doi:10.2147/IJN.S273713.
   Web of Science ®Google Scholar
• Sheikhsaran F, Sadeghpour H, Khalvati B, Entezar-Almahdi E, Dehshahri A. Tetraiodothyroacetic acid-conjugated polyethylenimine for integrin receptor-mediated delivery of the plasmid encoding IL-12 gene. Colloids Surf B Biointerfaces. 2017;150:426–436. doi:10.1016/j.colsurfb.2016.11.00827847224
   PubMed Web of Science ®Google Scholar
• Sadeghpour H, Khalvati B, Entezar-Almahdi E, et al. Double domain polyethylenimine-based nanoparticles for integrin receptor mediated delivery of plasmid DNA. Sci Rep. 2018;8(1):1–12. doi:10.1038/s41598-018-25277-z29311619
   PubMedGoogle Scholar
• Mahmoudi R, Ashraf Mirahmadi-Babaheidri S, Delaviz H, et al. RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells. J Biomater Appl. 2020;088532822094936. doi:10.1177/0885328220949367
   Web of Science ®Google Scholar
• Treuel L, Jiang X, Nienhaus GU. New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface. 2013;10(82):20120939. doi:10.1098/rsif.2012.093923427093
   PubMed Web of Science ®Google Scholar
• Strobel C, Oehring H, Herrmann R, Förster M, Reller A, Hilger I. Fate of cerium dioxide nanoparticles in endothelial cells: exocytosis. J Nanoparticle Res. 2015;17:206. doi:10.1007/s11051-015-3007-4
   PubMed Web of Science ®Google Scholar
• Oh N, Park J-H-H. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine. 2014;9(SUPPL.1):51–63. doi:10.2147/IJN.S2659224872703
   PubMed Web of Science ®Google Scholar
• Kettler K, Krystek P, Giannakou C, Hendriks AJ, Jong WHD. Exploring the effect of silver nanoparticle size and medium composition on uptake into pulmonary epithelial 16HBE14o-cells. J Nanoparticle Res. 2016;18(7):1–11. doi:10.1007/s11051-016-3493-z
   Web of Science ®Google Scholar
• Salvati A, Åberg C, Dos Santos T, et al. Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomed Nanotechnol Biol Med. 2011;7(6):818–826. doi:10.1016/j.nano.2011.03.005
   PubMed Web of Science ®Google Scholar
• Guarnieri D, Guaccio A, Fusco S, Netti PA. Effect of serum proteins on polystyrene nanoparticle uptake and intracellular trafficking in endothelial cells. J Nanoparticle Res. 2011;13:4295–4309. doi:10.1007/s11051-011-0375-2
   Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel. Comput Methods Programs Biomed. 2010;99(3):306–314. doi:10.1016/j.cmpb.2010.01.00720176408
   PubMed Web of Science ®Google Scholar
• Gunn J, Park SI, Veiseh O, Press OW, Zhang M. A pretargeted nanoparticle system for tumor cell labeling. Mol Biosyst. 2011;7(3):742–748. doi:10.1039/c005154c21107453
   PubMedGoogle Scholar
• Yin Y, Chen D, Qiao M, Wei X, Hu H. Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution. J Control Release. 2007;123(1):27–38. doi:10.1016/j.jconrel.2007.06.02417728000
   PubMed Web of Science ®Google Scholar
• Matsuo K, Itoh T, Koyama A, et al. CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma. Cancer Lett. 2016;378(1):16–22. doi:10.1016/j.canlet.2016.04.03927132989
   PubMed Web of Science ®Google Scholar
• Bertrand N, Grenier P, Mahmoudi M, et al. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Nat Commun. 2017;8(1). doi:10.1038/s41467-017-00600-w
   Google Scholar
• Rafiei P, Haddadi A. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine. 2017;12:935–947. doi:10.2147/IJN.S12188128184163
   PubMed Web of Science ®Google Scholar
• Kudgus RA, Walden CA, McGovern RM, Reid JM, Robertson JD, Mukherjee P. Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component. Sci Rep. 2015;4(1):5669. doi:10.1038/srep05669
   Google Scholar
• Mehrotra A, Kumar Pandit J. Preparation and characterization and biodistribution studies of lomustine loaded PLGA nanoparticles by interfacial deposition method. J Nanomedicine Biotherapeutic Discov. 2015;05(04). doi:10.4172/2155-983X.1000138
   Google Scholar
• Shalgunov V, Zaytseva-zotova D, Zintchenko A, et al. Comprehensive study of the drug delivery properties of poly (L-lactide)-poly (ethylene glycol) nanoparticles in rats and tumor-bearing mice. J Control Release. 2017;261:31–42. doi:10.1016/j.jconrel.2017.06.00628611009
   PubMed Web of Science ®Google Scholar
• Peñaloza JP, Márquez-Miranda V, Cabaña-Brunod M, et al. Intracellular trafficking and cellular uptake mechanisms of PHBV nanoparticles for targeted delivery in epithelial cell lines. J Nanobiotechnology. 2017;15(1). doi:10.1083/jcb.201002027
   PubMedGoogle Scholar
• Cui Y, Song X, Li S, et al. The impact of receptor recycling on the exocytosis of Αvβ3 integrin targeted gold nanoparticles. Oncotarget. 2017;8(24):38618–38630. doi:10.18632/oncotarget.1695528454098
   PubMedGoogle Scholar
• Qiu L, Hu Q, Cheng L, et al. CRGDyK modified PH responsive nanoparticles for specific intracellular delivery of doxorubicin. Acta Biomater. 2016;30:285–298. doi:10.1016/j.actbio.2015.11.03726602824
   PubMed Web of Science ®Google Scholar
• Sebak AA. Limitations of PEGylated nanocarriers: unfavourable physicochemical properties, biodistribution patterns and cellular and subcellular fates. Int J Appl Pharm. 2018;10(5):6–12. doi:10.22159/ijap.2018v10i5.27568
   PubMedGoogle Scholar
• Alipour M, Baneshi M, Hosseinkhani S, et al. Recent progress in biomedical applications of RGD-based ligand: from precise cancer theranostics to biomaterial engineering: a systematic review. J Biomed Mater Res Part A. 2020;108(4):839–850. doi:10.1002/jbm.a.36862
   PubMed Web of Science ®Google Scholar
• Liu P, Sun Y, Wang Q, Sun Y, Li H, Duan Y. Intracellular trafficking and cellular uptake mechanism of MPEG-PLGA-PLL and MPEG-PLGA-PLL-gal nanoparticles for targeted delivery to hepatomas. Biomaterials. 2014;35(2):760–770. doi:10.1016/j.biomaterials.2013.10.02024148242
   PubMed Web of Science ®Google Scholar
• Claudia M, Kristin Ö, Jennifer O, Eva R, Eleonore F. Comparison of fluorescence-based methods to determine nanoparticle uptake by phagocytes and non-phagocytic cells in vitro. Toxicology. 2017;378:25–36. doi:10.1016/j.tox.2017.01.00128065592
   PubMed Web of Science ®Google Scholar
• Tedja R, Lim M, Amal R, Marquis C. Effects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell lines. ACS Nano. 2012;6(5):4083–4093. doi:10.1021/nn300484522515565
   PubMed Web of Science ®Google Scholar
• Reinholz J, Diesler C, Schöttler S, et al. Protein machineries defining pathways of nanocarrier exocytosis and transcytosis. Acta Biomater. 2018;71:432–443. doi:10.1016/j.actbio.2018.03.00629530823
   PubMed Web of Science ®Google Scholar
• Hu L, Mao Z, Zhang Y, Gao C. Influences of size of silica particles on the cellular endocytosis, exocytosis and cell activity of HepG2 cells. J Nanosci Lett. 2011;1.
   PubMedGoogle Scholar
• Sakhtianchi R, Minchin RF, Lee K-B, Alkilany AM, Serpooshan V, Mahmoudi M. Exocytosis of nanoparticles from cells: role in cellular retention and toxicity. Adv Colloid Interface Sci. 2013;201–202:18–29. doi:10.1016/j.cis.2013.10.013
   PubMed Web of Science ®Google Scholar
• Li Q, Xia D, Tao J, et al. Self-assembled core-shell-type lipid-polymer hybrid nanoparticles: intracellular trafficking and relevance for oral absorption. J Pharm Sci. 2017;106(10):3120–3130. doi:10.1016/j.xphs.2017.05.02928559042
   PubMed Web of Science ®Google Scholar
• Panariti A, Miserocchi G, Rivolta I. The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol Sci Appl. 2012;5(1):87–100. doi:10.2147/NSA.S2551524198499
   PubMedGoogle Scholar
• Shang L, Nienhaus K, Nienhaus G. Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnology. 2014;12(1):5. doi:10.1186/1477-3155-12-524491160
   PubMed Web of Science ®Google Scholar
• Salatin S, Yari Khosroushahi A. Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles. J Cell Mol Med. 2017;XX(X):1–19. doi:10.1111/jcmm.13110
   Google Scholar
• Kettiger H, Schipanski A, Wick P, Huwyler J. Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomedicine. 2013;8(August):3255–3269. doi:10.2147/IJN.S4977024023514
   PubMedGoogle Scholar
• Guan X, Chen J, Hu Y, et al. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase. Biomaterials. 2018;171:198–206. doi:10.1016/j.biomaterials.2018.04.03929698869
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang L, Lv P, Zhang P. Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer. Oncol Lett. 2015;9(3):1065–1072. doi:10.3892/ol.2014.284025663858
   PubMed Web of Science ®Google Scholar
• Wu M, Guo H, Liu L, Liu Y, Xie L. Size-dependent cellular uptake and localization profiles of silver nanoparticles. Int J Nanomedicine. 2019;14:4247–4259. doi:10.2147/IJN.S20110731239678
   PubMed Web of Science ®Google Scholar
• Ekkapongpisit M, Giovia A, Follo C, Caputo G, Isidoro C. Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups. Int J Nanomedicine. 2012;7:4147–4158. doi:10.2147/IJN.S3380322904626
   PubMed Web of Science ®Google Scholar
• Slowing II, Vivero-Escoto JL, Zhao Y, et al. Exocytosis of mesoporous silica nanoparticles from mammalian cells: from asymmetric cell-to-cell transfer to protein harvesting. Small. 2011;7(11):1526–1532. doi:10.1002/smll.20100207721520497
   PubMed Web of Science ®Google Scholar
• Palchetti S, Pozzi D, Capriotti AL, et al. Influence of dynamic flow environment on nanoparticle-protein corona: from protein patterns to uptake in cancer cells. Colloids Surf B Biointerfaces. 2017;153:263–271. doi:10.1016/j.colsurfb.2017.02.03728273493
   PubMed Web of Science ®Google Scholar
• Su G, Jiang H, Xu B, Yu Y, Chen X. Effects of protein corona on active and passive targeting of cyclic RGD peptide-functionalized PEGylation nanoparticles. Mol Pharm. 2018;15(11):5019–5030. doi:10.1021/acs.molpharmaceut.8b0061230222356
   PubMedGoogle Scholar
• Xiao W, Gao H. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system. Int J Pharm. 2018;552(1–2):328–339. doi:10.1016/j.ijpharm.2018.10.01130308270
   PubMedGoogle Scholar
• Ritz S, Schöttler S, Kotman N, et al. Protein corona of nanoparticles: distinct proteins regulate the cellular uptake. Biomacromolecules. 2015;16(4):1311–1321. doi:10.1021/acs.biomac.5b0010825794196
   PubMed Web of Science ®Google Scholar
• Chen D, Ganesh S, Wang W, Amiji M. Plasma protein adsorption and biological identity of systemically administered nanoparticles. Nanomedicine (Lond). 2017;12(17):2113–2135. doi:10.2217/nnm-2017-017828805542
   PubMed Web of Science ®Google Scholar
• Palchetti S, Digiacomo L, Pozzi D, et al. Nanoparticles-cell association predicted by protein corona fingerprints †. Nanoscale. 2016;8:12755. doi:10.1039/c6nr03898k27279572
   PubMed Web of Science ®Google Scholar
• Caracciolo G, Cardarelli F, Pozzi D, et al. Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles. ACS Appl Mater Interfaces. 2013;5(24):13171–13179. doi:10.1021/am404171h24245615
   PubMed Web of Science ®Google Scholar
• Rosso F, Marino G, Grimaldi A, et al. Vitronectin absorbed on nanoparticles mediate cell viability/proliferation and uptake by 3T3 Swiss Albino mouse fibroblasts: in vitro study. Biomed Res Int. 2013;2013:1–10. doi:10.1155/2013/539348
   Web of Science ®Google Scholar
• Gilkey MJ, Krishnan V, Scheetz L, Jia X, Rajasekaran A, Dhurjati P. Physiologically based pharmacokinetic modeling of fluorescently labeled block copolymer nanoparticles for controlled drug delivery in leukemia therapy. CPT Pharma Syst Pharmacol. 2015;4(3):e00013. doi:10.1002/psp4.13
   PubMedGoogle Scholar
• Mohammad AK, Reineke JJ. Quantitative detection of PLGA nanoparticle degradation in tissues following intravenous administration. Mol Biol Cell. 2013;10:2183–2189. doi:10.1021/mp300559v
   Google Scholar
• Godara S, Lather V, Kirthanashri SV, Awasthi R, Pandita D. Lipid-PLGA hybrid nanoparticles of paclitaxel: preparation, characterization, in vitro and in vivo evaluation. Mater Sci Eng C. 2020;109:110576. doi:10.1016/j.msec.2019.110576
   PubMed Web of Science ®Google Scholar
• Ahmed IS, El Hosary R, Hassan MA, Haider M, Abd-Rabo MM. Efficacy and safety profiles of oral atorvastatin-loaded nanoparticles: effect of size modulation on biodistribution. Mol Pharm. 2018;15(1):247–255. doi:10.1021/acs.molpharmaceut.7b0085629232954
   PubMedGoogle Scholar
• Alalaiwe A, Carpinone P, Alshahrani S, et al. Influence of chitosan coating on the oral bioavailability of gold nanoparticles in rats. Saudi Pharm J. 2019;27(2):171–175. doi:10.1016/j.jsps.2018.09.01130766426
   PubMed Web of Science ®Google Scholar
• Wu C, Mu H. Lipid and PLGA microparticles for sustained delivery of protein and peptide drugs. PharmNanotechnol. 2019;07. doi:10.2174/2211738507666191029160944.
   Google Scholar
• Navarro SM, Darensbourg C, Cross L, et al. Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days. Ther Deliv. 2014;5(11):1191–1201. doi:10.4155/tde.14.7925491670
   PubMedGoogle Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–951. doi:10.1038/nbt.333026348965
   PubMed Web of Science ®Google Scholar
• Yu T, Hubbard D, Ray A, Ghandehari H. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J Control Release. 2012;163:46–54. doi:10.1016/j.jconrel.2012.05.04622684119
   PubMed Web of Science ®Google Scholar
• Jack Hu C-M, Kaushal S, Tran Cao HS, et al. Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to Carcinoembryonic Antigen (CEA) presenting pancreatic cancer cells. Mol Pharm. 2010;7(3):914–920. doi:10.1021/mp900316a20394436
   PubMedGoogle Scholar
• Palchetti S, Pozzi D, Mahmoudi M, Caracciolo G. Exploitation of nanoparticle-protein corona for emerging therapeutic and diagnostic applications. J Mater Chem B. 2016;4(25):4376–4381. doi:10.1039/c6tb01095d32263419
   PubMed Web of Science ®Google Scholar
• Shen L, Tenzer S, Storck W, et al. Protein corona–mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses. J Allergy Clin Immunol. 2018;142(5):1558–1570. doi:10.1016/j.jaci.2017.08.04929382591
   PubMed Web of Science ®Google Scholar
• Nagayama S, Ogawara KI, Fukuoka Y, Higaki K, Kimura T. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm. 2007;342(1–2):215–221. doi:10.1016/j.ijpharm.2007.04.03617566676
   PubMed Web of Science ®Google Scholar
• Mirshafiee V, Kim R, Park S, Mahmoudi M, Kraft ML. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. Biomaterials. 2016;75:295–304. doi:10.1016/j.biomaterials.2015.10.01926513421
   PubMed Web of Science ®Google Scholar
• Schöttler S, Klein K, Landfester K, Mailänder V. Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. Nanoscale. 2016;8(10):5526–5536. doi:10.1039/c5nr08196c26804616
   PubMed Web of Science ®Google Scholar
• Bros M, Nuhn L, Simon J, et al. The protein corona as a confounding variable of nanoparticle-mediated targeted vaccine delivery. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.01760.
   PubMed Web of Science ®Google Scholar
• Schöttler S, Becker G, Winzen S, et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat Nanotechnol. 2016;11(4):372–377. doi:10.1038/nnano.2015.33026878141
   PubMed Web of Science ®Google Scholar
• Aoyama M, Hata K, Higashisaka K, Nagano K, Yoshioka Y, Tsutsumi Y. Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes. Biochem Biophys Res Commun. 2016;480(4):690–695. doi:10.1016/j.bbrc.2016.10.12127983983
   PubMed Web of Science ®Google Scholar